Small Pharmaceuticals
Market Cap
₹18,126 ₹18,126 Cr.
P/E
57.53
PEG
4.02
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

  • Poly Medicure
  • TTK Healthcare
  • 3B Blackbio Dx

FAQs on Poly Medicure Ltd. Shareprice

Poly Medicure has given better returns compared to its competitors.
Poly Medicure has grown at ~8.55% over the last 3yrs while peers have grown at a median rate of -0.83%

Poly Medicure is not expensive.
Latest PE of Poly Medicure is 57.53, while 3 year average PE is 61.67.
Also latest EV/EBITDA of Poly Medicure is 39.84 while 3yr average is 44.22.

Growth Table

  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Balance Sheet

  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Cash Flow

  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Quarterly Results

  • Poly Medicure Ltd.
  • TTK Healthcare
  • 3B Blackbio Dx

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Poly Medicure Ltd. Financials

Balance sheet of Poly Medicure is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Poly Medicure is increasing.
Latest net debt of Poly Medicure is ₹166 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹124.84 Crs.

No, profit is decreasing.
The profit of Poly Medicure is ₹307 Crs for TTM, ₹322 Crs for Mar 2026 and ₹339 Crs for Mar 2025.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Poly Medicure latest dividend payout ratio is 11.01% and 3yr average dividend payout ratio is 10.88%

Companies resources are allocated to majorly productive assets like Plant & Machinery

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech